A randomized phase III study comparing gemcitabine monotherapy with observation in patients with resected pancreatic cancer

被引：1
|
作者：
Kosuge, T. [1 ]
Ueno, H. [1 ]
Matsuyama, Y. [2 ]
Yamamoto, J. [3 ]
Nakao, A. [4 ]
Egawa, S. [5 ]
Doi, R. [6 ]
Monden, M. [7 ]
Hatori, T. [8 ]
Tanaka, M. [9 ]
机构：
[1] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan
[2] Univ Tokyo, Dept Biostat, Tokyo, Japan
[3] Canc Inst Hosp, Dept Gastrointestinal Surg, Tokyo, Japan
[4] Nagoya Univ, Dept Surg 2, Aichi, Japan
[5] Tohoku Univ, Div Gastroenterol, Sendai, Miyagi 980, Japan
[6] Kyoto Univ, Dept Surg, Kyoto, Japan
[7] Osaka Univ, Dept Surg & Clin Oncol, Osaka, Japan
[8] Tokyo Womens Med Univ, Dept Surg, Tokyo, Japan
[9] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71007-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3504
引用
收藏
页码：260 / 260
页数：1
相关论文
共 50 条
  • [1] A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
    H Ueno
    T Kosuge
    Y Matsuyama
    J Yamamoto
    A Nakao
    S Egawa
    R Doi
    M Monden
    T Hatori
    M Tanaka
    M Shimada
    K Kanemitsu
    British Journal of Cancer, 2009, 101 : 908 - 915
  • [2] A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
    Ueno, H.
    Kosuge, T.
    Matsuyama, Y.
    Yamamoto, J.
    Nakao, A.
    Egawa, S.
    Doi, R.
    Monden, M.
    Hatori, T.
    Tanaka, M.
    Shimada, M.
    Kanemitsu, K.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 908 - 915
  • [3] A phase II/III study comparing intravenous ZD9331 with gemcitabine in patients with pancreatic cancer
    Smith, D
    Gallagher, N
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (10) : 1377 - 1383
  • [4] A randomized phase III study of irinotecan/gemcitabine combination versus gemcitabine in patients with advanced/metastatic pancreatic cancer.
    Stathopoulos, GP
    Aravantinos, G
    Syrigos, K
    Kalbakis, K
    Karvounis, N
    Papakotoulas, P
    Boukovinas, J
    Potamianou, A
    Polyzos, A
    Christophilakis, CH
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [5] BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
    Goncalves, A.
    Gilabert, M.
    Francois, E.
    Dahan, L.
    Perrier, H.
    Lamy, R.
    Re, D.
    Largillier, R.
    Gasmi, M.
    Tchiknavorian, X.
    Esterni, B.
    Genre, D.
    Moureau-Zabotto, L.
    Giovannini, M.
    Seitz, J-F.
    Delpero, J-R.
    Turrini, O.
    Viens, P.
    Raoul, J-L.
    ANNALS OF ONCOLOGY, 2012, 23 (11) : 2799 - 2805
  • [6] A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer.
    Neuhaus, P
    Oettle, H
    Post, S
    Gellert, K
    Ridwelski, K
    Schramm, H
    Zülke, C
    Fahlke, G
    Langrehr, J
    Riess, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1092S - 1092S
  • [7] CONKO-001: FINAL RESULTS OF THE RANDOMIZED, PROSPECTIVE, MULTICENTER PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY WITH GEMCITABINE VERSUS OBSERVATION IN PATIENTS WITH RESECTED PANCREATIC CANCER (PC)
    Riess, H.
    Neuhaus, P.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 45 - 46
  • [8] CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)
    Neuhaus, P.
    Riess, H.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
    Bao, Philip Q.
    Ramanathan, Ramesh K.
    Krasinkas, Alyssa
    Bahary, Nathan
    Lembersky, Barry C.
    Bartlett, David L.
    Hughes, Steven J.
    Lee, Kenneth K.
    Moser, A. James
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1122 - 1129
  • [10] Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
    A W Blackstock
    F Mornex
    C Partensky
    L Descos
    L D Case
    S A Melin
    E A Levine
    G Mishra
    S A Limentani
    L A Kachnic
    J E Tepper
    British Journal of Cancer, 2006, 95 : 260 - 265
12345